Form 4: FMC Corp Director K'Lynne Johnson Acquires Shares Through Dividend Equivalent Rights
SEC Form 4 Filing
Director K'Lynne Johnson acquired 190 shares of FMC Corp common stock on April 18, 2024, through dividend equivalent rights related to vested restricted stock units.
Summary
- On April 18, 2024, K'Lynne Johnson, a director of FMC Corp, acquired 190 shares of common stock.
- The acquisition was a result of dividend equivalent rights associated with vested restricted stock units.
- The price per share was $0.
- Following the transaction, Johnson directly owns 27,547 shares of FMC Corp common stock.
- A power of attorney is in place, authorizing Michael F. Reilly and Zakiya Barnett to execute Forms 3, 4, and 5 on Johnson's behalf.
Sentiment
Score: 6
Explanation: The document reflects a routine transaction related to executive compensation. It is neither particularly positive nor negative, but rather a standard disclosure.
Positives
- The acquisition of shares through dividend equivalent rights indicates that the director is receiving value from their vested restricted stock units.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. This particular filing reflects the acquisition of shares through dividend equivalent rights, which is a common form of compensation for executives and directors.
Comparison to Industry Standards
- Comparing K'Lynne Johnson's holdings and transactions to those of other directors in similar agricultural sciences companies would provide a benchmark for assessing the significance of this transaction.
- Analyzing the prevalence of dividend equivalent rights as part of executive compensation packages in the industry would offer context for understanding the nature of this acquisition.
- Companies like Corteva, Bayer Crop Science, and Syngenta could be considered for comparison in terms of insider ownership and compensation structures.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine acquisition of shares by a director.
- It provides transparency to shareholders regarding insider ownership.
Key Dates
| Date | Description |
|---|---|
| 2024-02-06 | Date of Power of Attorney execution. |
| 2024-04-18 | Date of transaction: Acquisition of 190 shares of common stock. |
| 2024-04-22 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.